Vital Technologies, an Israeli supplements startup developing pharma-class recovery beverage products, raised $8m in funding to date.
Backers included private investors in the USA and Israel.
The company is using the funds for R&D, production and marketing of CUUR® in the USA.
Founded in 2015 and led by CEO Amir Barzilay, Vital Technologies is a supplements life-science company that develops and markets fast-acting, pharma-class recovery beverage products for healthy individuals who undergo daily transient physiological and cognitive stress episodes which are typical to the demanding modern lifestyle.
The company has just launched CUUR®, its solution to preemptively target the symptoms caused by alcohol consumption.
CUUR® is manufactured in a pharma-class GMP facility registered with the U.S. Food and Drug Administration.
The team also includes:
– Irit Livny – VP Marketing
– Doron Polity – VP Operations
– Dr. Michael Fox – Head of Formulation Development